BOSTON--(BUSINESS WIRE)--20/20 Onsite, a mobile optometry and life sciences company, is pleased to announce the appointment of Sonali Bloom as the new Chief Executive Officer. Bloom is moving up from the role of VP of Product and Experience with a four-year tenure at the company. She is honored to lead and guide the team in its mission to make high-quality vision care more widely accessible.
With a big growth year ahead, 20/20 Onsite, a Boston-based mobile optometry company whose mission is to deliver more accessible vision care, announces a leadership change as its Vice President of Product and Experience, Sonali Bloom, has been named Chief Executive Officer, effective April 12th, 2022.
Bloom first joined 20/20 Onsite in 2017 as a post-MBA intern. Since joining full time in 2018, Bloom has held various leadership roles across client success, marketing, sales, technology, product development and operations.
Most recently, she led the Life Sciences business unit, which is focused on serving Biopharma sponsors and CROs conducting clinical research, becoming intimately familiar with the company’s work in clinical research and its astounding growth potential. Launched in the summer of 2020, the company’s Life Sciences practice conducts pre-screening for patients who may be eligible for clinical research, eye health assessments for clinical trial participants, and post-marketing safety surveillance programs.
“20/20 Onsite is exceedingly fortunate to have someone with Sonali Bloom’s experience, skills, education, and motivation taking on the CEO role at this exciting inflection point in the company’s growth,” says Tony Morris, Board Chair of 20/20 Onsite. “Sonali has demonstrated both insightful understanding of the opportunities we are addressing as well as leadership, agility, and operational effectiveness in advancing our mobile care delivery model in two very large and complementary markets.”
Bloom holds a BS in Physics from Yale University and an MBA with Distinction from Harvard Business School.
As someone who can barely see without glasses, Bloom feels very connected to 20/20 Onsite’s mission to go the extra mile to make high-quality vision care more accessible, creating healthier and happier patients, families, and communities.
“At 20/20 Onsite, we place our patients at the center of all we do. We take every opportunity to bring care directly to patients who wouldn’t otherwise receive care, endeavoring to eliminate every friction or inconvenience along the way,” says Bloom. “In my 4 years here, it has been tremendously rewarding to see how we have expanded access to care for our optometry patients. Our focus on delivering the same experience to clinical trial participants through our mobile clinics is game-changing, and one of the reasons I am so excited to step into this role.”
Bloom has played an integral role in 20/20 Onsite’s innovations to date, including being a driving force behind the company’s recent rebrand, the launch of three new Mobile Vision Clinics and the restart of the pro bono Boston Public Schools program in the first quarter of 2022. Before the pandemic, she led the development and growth of the Routine Optometry business. During the pandemic shutdown, she oversaw the reengineering of customer success processes and delivery capacity including the refinement of the integrated systems backbone that guides operations. With her experience in various roles across every segment of the business, Bloom has had the opportunity to work closely with nearly every team member at 20/20 Onsite. She now can take her leadership role to the next level as CEO.
“Sonali’s perspectives, creativity, and energy have helped us grow to where we are today,” says Ivan Quiroz, VP, Clinic Operations. “I’ve seen Sonali tackle challenges and adapt to circumstances that would break most leaders, and I am excited to help 20/20 Onsite accelerate its impact with Sonali in the driver’s seat!”
Former CEO Alexis McLaughlin left the company in April, and is returning to her consumer retail roots as the CEO of a startup in the veterinary care market. “We thank Alexis and wish her great success in her new venture,” says Morris, Board Chair. “The Board and I are greatly looking forward to Sonali’s energetic leadership as 20/20 Onsite brings a compelling solution to the patient access challenge faced throughout the healthcare and wellness sectors.”
20/20 Onsite is on target to nearly double its business activity this year due to the expansion of its Life Sciences practice and the growing client list in its Routine Optometry practice. The team continues to deliver new innovations in vision care and shows no signs of slowing down.
About 20/20 Onsite:
20/20 Onsite is a health care services company that is transforming the delivery of vision care by radically improving access for patients through state-of-the-art Mobile Vision Clinics. Since 2014 our integrated mobile service delivery platform has taken high value eye care services directly to patients at work, at school, and more recently, at convenient neighborhood locations in the Northeast. In the midst of the pandemic, 20/20 Onsite began bringing ophthalmic assessments to patients in clinical trials or post-marketing safety surveillance programs across the country, increasing access to clinical research. We are disrupting the way eye care is delivered, and we are enabling and accelerating fundamental trends toward the consumerization of care and the decentralization of clinical trials. We serve 400+ corporate clients, educational institutions, and other organizations with comprehensive eye care for their employees, and our patient base of 70,000+ consistently reports NPS over 92.
Learn more: www.2020onsite.com